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Skeletal muscle makes up approximately 40% of the total body mass, providing structural
support and enabling the body to maintain posture, to control motor movements and to
store energy. It therefore plays a vital role in whole body metabolism. Skeletal muscle
displays remarkable plasticity and is able to alter its size, structure and function in response
to various stimuli; an essential quality for healthy living across the lifespan. Exercise is an
important stimulator of extracellular and intracellular stress signals that promote positive
adaptations in skeletal muscle. These adaptations are controlled by changes in gene
transcription and protein translation, with many of these molecules identified as potential
therapeutic targets to pharmacologically improve muscle quality in patient groups too ill
to exercise. MicroRNAs (miRNAs) are recently identified regulators of numerous gene
networks and pathways and mainly exert their effect by binding to their target messenger
RNAs (mRNAs), resulting in mRNA degradation or preventing protein translation. The role
of exercise as a regulatory stimulus of skeletal muscle miRNAs is now starting to be
investigated. This review highlights our current understanding of the regulation of skeletal
muscle miRNAs with exercise and disease as well as how they may control skeletal
muscle health.
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INTRODUCTION
Maintaining skeletal muscle metabolism, size and contractile
function are prerequisites for whole body health throughout life.
Skeletal muscle is highly sensitive to extracellular and intracellu-
lar signals elicited by contractions from endurance and resistance
exercise. These signals are the catalyst for numerous physiological
adaptations including enhanced substrate metabolism, mito-
chondrial biogenesis, angiogenesis, muscle growth and regenera-
tion (Hawke, 2005; Hawley et al., 2006; Léger et al., 2006; Russell,
2010). In contrast, a lack of exercise and muscle contraction, as
seen in numerous neuromuscular, musculoskeletal and chronic
diseases, as well as in limb immobilization following trauma,
sedentary lifestyles or with ageing, negatively impacts on skeletal
muscle metabolism, size and contractile function. These negative
responses play a role in the on-set and progression of secondary
diseases, such as diabetes and cardiovascular disease, increase the
severity of chronic diseases and limit the availability of treatment
options.
Extracellular and intracellular signals, activated by exercise or
disease and inactivity, influence transcriptional and translational
regulation of genes encoding proteins that control skeletal muscle
metabolism, growth, regeneration and contraction (Dela et al.,
1994; Russell et al., 2003, 2005; Short et al., 2003; Wadley et al.,
2007). The control of these transcription and translation pro-
cesses is regulated by transcription factor activation (Keller et al.,
2001; McGee et al., 2006), histone modification (McGee et al.,
2009) and DNA methylation (Nakajima et al., 2010; Barres et al.,
2012). However, the discovery of microRNAs (miRNAs) (Lee
et al., 1993; Reinhart et al., 2000) has revealed another level of
complexity in transcriptional and translational regulation (Bartel,
2004). Our understanding of how exercise and disease regulate
miRNA expression and activity as well as their messenger RNA
(mRNA) targets implicated in skeletal muscle health is rudi-
mentary. Exploring this field will advance our knowledge of the
mechanisms behind skeletal muscle health and disease and poten-
tially reveal novel therapeutic targets that may be used as a means
to improve health outcomes for people suffering from muscular
disorders.
THE REGULATION OF mRNAs BY MicroRNAs
MiRNAs play an imperative role in the maintenance of healthy
cellular function. The primary role of miRNAs is to specifically
inhibit protein expression (Olsen and Ambros, 1999; Lee et al.,
2004; Wightman et al., 2004; Humphreys et al., 2005; Pillai et al.,
2005; Huili et al., 2010) and this can be achieved either by degrad-
ing specific mRNA species or by repressing protein translation.
Overall, mRNA degradation accounts for the majority of miRNA
activity (Huili et al., 2010). The precise mechanism of miRNA tar-
geting and activity still remains to be fully understood. However,
miRNA activity appears to be largely dependent on its binding
capacity to the target mRNA molecule (Brennecke et al., 2005;
Hu and Bruno, 2011). Most miRNA binding sites are located in
the 3′ untranslated region (UTR) of the target mRNA species and
exist in multiple copies (Hu and Bruno, 2011). There are 2 known
binding types for miRNAs (Brennecke et al., 2005). The first is
perfect Watson-Crick complementary binding between the 5′ end
of the miRNA and the 3′ UTR of the target mRNA; although
some miRNA can target the 5′ UTR. This region of the miRNA
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is called the “seed” region, occurring at base position 2–8 on
the 5′ end of the miRNA. This perfect binding within the seed
region is sufficient to suppress mRNA activity on its own. The
second type of binding is imperfect binding between the seed
region and the 3′ UTR but with compensatory binding at the 3′
end of the mRNA molecule. Figure 1 depicts the possible types
of miRNA/mRNA interactions along with the effect of miRNA
binding on mRNA degradation and translational repression.
Understanding how miRNAs target and bind mRNAs has led
to the development of a number of different algorithms and
bioinformatics websites such as miRWalk and TargetScan (Lewis
et al., 2005; Dweep et al., 2011). These softwares are commonly
used to predict specific mRNA/miRNA interactions. However,
miRNA binding rules are complex and are not completely under-
stood, resulting in a lack of consensus in the literature. Foremost,
establishing direct cause-and-effect links between miRNAs and
mRNA targets is key to understanding the underlying molecular
mechanisms behind health and disease and thus the development
of effective and targeted therapies.
REGULATION OF MicroRNA BIOGENESIS MACHINERY
MiRNA biogenesis is a complex process requiring co-ordination
of primary miRNA (pri-miRNA) transcription in the nucleus.
The pri-miRNA is cleaved by the RNase-III type endonuclease
Drosha associated with Pasha (also known as DGCR8) into a pre-
cursor molecule referred to as the pre-miRNA. The pre-miRNA
is then exported into the cytoplasm by exportin 5 (XPO5) and
cleaved a second time by Dicer (Lee et al., 2003; Lund et al., 2004).
This gives rise to a duplex strand that is unwound by RNA heli-
cases. The miRNA strands are separated and incorporated into
the RNA-induced silencing complex (RISC), providing specificity
for the RISC to identify and bind to the 3′ or 5′ UTR of the
target mRNAs (Khvorova et al., 2003; Bartel, 2004; Lee et al.,
2009). There has been very little investigation into the exercise-
induced regulation of the miRNA biogenesis machinery. Work
from our group has shown that in the 3 h following a single bout
of endurance exercise in untrained males there is an increase in
XPO5 mRNA as well as Drosha and Dicer mRNA (Russell et al.,
2013). XPO5 and Drosha mRNA are also increased in old but not
young subjects within 6 h following a single bout of resistance
exercise (Drummond et al., 2008b). Interestingly, this change
FIGURE 1 | Schematic representation of possible miRNA—mRNA
interactions. (A) Perfect Watson-Crick complementary binding. (B)
Imperfect binding, with compensatory binding at the 3′ end of the mRNA
molecule. Once bound to the mRNA molecule, the miRNA can either (C)
inhibit protein translation, or (D) induce mRNA degradation.
occurred in parallel with a decrease in XPO5 protein levels in
both groups. In addition to its role in exporting pre-miRNA from
the nucleus to the cytoplasm, XPO5 also stabilizes pre-miRNAs
(Lund et al., 2004), suggesting that XPO5 increases the pool of
pre-miRNAs. The upregulation of XPO5 in skeletal muscle fol-
lowing exercise may be an adaptive response to aid processing
of new pre-miRNAs that regulate exercise-induced adaptations in
muscle. However, further work is required to elucidate the regu-
lation and expression of miRNA biogenesis machinery in muscle
and to understand how this affects the miRNA pool.
REGULATION OF MicroRNAs IN HEALTHY MUSCLE AND
EXERCISE
Many miRNAs can be highly and specifically enriched in cer-
tain tissues (Sood et al., 2006). Skeletal muscle enriched miRNAs,
referred to as myomiRs, include miR-1, miR-133a, miR-133b,
miR-206, miR-208, miR-208b, miR-486 and miR-499 (McCarthy
and Esser, 2007; Callis et al., 2008). The transcriptional regula-
tion of muscle enriched miRNAs is under the control of myogenic
regulatory factors (MRFs), such as MyoD, myogenin, Myf5 and
MRF4 (Rao et al., 2006; Rosenberg et al., 2006), that tightly con-
trol skeletal muscle regeneration (Rudnicki and Jaenisch, 1995;
Tajbakhsh et al., 1996; Sabourin and Rudnicki, 2000). These miR-
NAs can be arranged in polycistronic clusters and transcribed
together or in parallel with protein-coding genes (Sweetman
et al., 2008). MiRNAs expressed in skeletal muscle are modulated
during multiple biological processes involved in skeletal muscle
growth, development and maintenance, including atrophy and
hypertrophy (McCarthy and Esser, 2007; McCarthy et al., 2007,
2009).
Skeletal muscle atrophy and hypertrophy models have been
used to characterize the role and regulation of miRNAs poten-
tially involved in maintaining skeletal muscle mass (see Table 1).
Following 7-days of hypertrophy-inducing functional overload
of the mouse plantaris muscle, expression of miR-1 and miR-
133a was decreased by 50% when compared to control muscle
(McCarthy and Esser, 2007). MiR-1 and miR-133a were pro-
posed to contribute to muscle hypertrophy by the removal of
their transcriptional inhibitory effect on growth factors such as
IGF-1. In support of this hypothesis a regulatory feedback loop
was demonstrated in vitro where IGF-1 downregulated miR-1 via
the Akt/FoxO3a pathway (Elia et al., 2009). It was also shown
that FoxO3a increased levels of miR-1 resulting in reduced IGF-1
protein levels.
Unloading of skeletal muscle by immobilization, hind limb
suspension (HS) or exposure to microgravity during space flights
decreases muscle mass (Allen et al., 2009; McCarthy et al., 2009).
Muscle immobilization in rats, induced by the laceration of the
tibialis anterior, is associated with a decrease in miR-1, miR-
133a and miR-206 levels 1 day post-intervention (Nakasa et al.,
2010). MiR-107, miR-221, miR-499 andmiR-208b were all down-
regulated following 7 days of rat HS (McCarthy et al., 2009).
Eleven days of spaceflight decreased miR-206 expression (Allen
et al., 2009). This decrease was paralleled by an upregulation of
FoxO1, atrogin-1 and myostatin mRNAs; all regulators of muscle
atrophy (Bodine et al., 2001; Kim et al., 2012). MiR-206 pro-
motes differentiation of C2C12 myoblasts (Kim et al., 2006) and
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Table 1 | Regulation of miRNAs by exercise and disuse.
Species Model Duration miRNAs regulated
MyomiRs Other miRNAs
Mouse 7 days
miR-
1 133a 206
Nakasa 
et al., 2010
Rat 1 days
1 133a 206
McCarthy 
et al., 2009
Rat
Immobilization 
Hind limb 
suspension
7 days
206 499 107 221
McCarthy 
et al., 2009
Rat 28 days
208b 499
Allen 
et al., 2009
Mouse 11 days
1 133a 206
Drummond 
et al., 2008b
Human
3 / 6 
hrs 1 133a 206
Davidsen 
et al., 2011
Human 12 wks
26a 29a 378 451
Keller 
et al., 2011
Human 6 wks
1 133a 101 455 144 15b 26b 28 29b 338 455 92 98 451 589
Keller 
et al., 2011
Human 6 wks
125a 183 189 432* 575 616 637
Nielsen 
et al., 2010
Human Endurance 
Training
12 wks
1 133a 133b 206
Human Endurance 10 days
miR-
miR-
miR- miR-
miR- miR-miR-
miR-miR-
miR-
miR- miR-
miR- miR- miR-
miR-
miR-
miR-
miR-
miR-miR-
miR- miR-
miR- miR- miR-miR-
miR- miR- miR- miR- miR- miR- miR- miR- miR- miR- miR- miR-miR-
miR- miR- miR- miR- miR- miR-miR-
miR-miR-
miR-
miR-
Immobilization
TA laceration 
Hypertrophy 
Functional 
overload
Immobilization 
Hind limb 
suspension
Unloading 
Spaceflight
Resistance 
Acute exercise 
bout
Endurance 
Training
Endurance 
Training
Training
Resistance 
Training 1 206 31 29b
Nielsen 
et al., 2010
Human
Endurance 
Acute exercise 
bout
1 hr
1 133 133b 206
Russell 
et al., 2013
Human
Endurance 
Acute exercise 
bout
3 hrs
1 133a 133b 206 31 9 23a 23b 181a
miR- miR-
miR-
miR-
miR-
miR-
miR-miR- miR- miR- miR- miR-miR-
Russell 
et al., 2013
McCarthy
et al., 2007 
Red, downregulated; Green, upregulated; Orange, no change.
skeletal muscle regeneration following injury in mice (Liu et al.,
2012). Whether miR-206 plays a direct or indirect role in repress-
ing the atrophy genes is unknown. However, atrogin-1 degrades
MyoD (Tintignac et al., 2005), which in turn positively regulates
miR-206 (Chen et al., 2006); however, the existence of a miR-
206/MyoD/atrogin-1 regulatory loop has not been investigated.
Exercise plays an important role in maintaining muscle health
throughout the lifespan, with resistance exercise a potent anabolic
stimulus enhancing muscle protein synthesis and muscle growth
(Fry, 2004; Léger et al., 2006; Kumar et al., 2009; Phillips, 2009;
Koopman et al., 2011). Few studies have investigated the changes
in skeletal muscle miRNA species following resistance exercise in
humans. MiR-1 expression is reduced 3 and 6 h following an sin-
gle bout of resistance exercise, while no changes were observed
in miR-133a and miR-206 levels (Drummond et al., 2008b).
Following a 12-week resistance-training program aimed at induc-
ing muscle hypertrophy, a difference in miRNA regulation was
observed in skeletal muscle of subjects defined as “high respon-
ders” vs. “low responders” to the resistance exercise training; “low
responders” having little or no muscle hypertrophy following the
training intervention (Davidsen et al., 2011). The training proto-
col resulted in an increase in skeletal muscle miR-451 expression
and a decrease in miR-26a, miR-29a and miR-378 expression
in the “low responder” group only. Low muscle hypertrophy
response to resistance exercise training in healthy young subjects
is referred to as anabolic resistance (Baar and Esser, 1999; Terzis
et al., 2008); a phenomenon also linked to age-related muscle
wasting or sarcopenia in the elderly. Whether miR-451, miR-26a,
miR-29a and miR-378 contributes to an attenuated hypertro-
phy response in young healthy subjects and the mechanisms they
control now requires experimental validation.
Endurance exercise is another modulator of skeletal muscle
miRNA expression. Following 12 weeks of endurance training,
expression of the myomiRs miR-1, miR-133a, miR-133b and
miR-206 were all significantly down regulated. These miRNAs
returned to pre-training baseline levels 2 weeks after the ces-
sation of training (Nielsen et al., 2010). In contrast, 10 days
of endurance training increased miR-1, concomitantly with an
increase in miR-29b and a decrease in miR-31 (Russell et al.,
2013). With respect to a single bout of endurance exercise, miR-
1 and miR-133a levels increased in the untrained state, however
this acute response was not observed in the trained state (Nielsen
et al., 2010). In addition, we observed that in the 3 h period fol-
lowing a single bout of endurance exercise, miR-1, -133a, -133-b
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and miR-181a were all increased. In contrast miR-9, -23a, -23b
and -31 were decreased (Russell et al., 2013). We also demon-
strated in vitro, via a reporter assay, that miR-31 directly interacts
with HDAC4 (Russell et al., 2013), a component of the MAPK
pathway (Symons et al., 2009), as well as with NRF1, which
is involved in mitochondrial biogenesis and metabolism. These
studies demonstrate that myomiR expression is sensitive to acute
and chronic endurance exercise, as well as inactivity. However,
their precise targets and the molecular processes regulated remain
to be established. Other studies found no correlation between
miRNA expression and components of the signaling pathways
involved in skeletal muscle adaptation to endurance exercise,
such as the MAPK pathway (Kramer and Goodyear, 2007) or
the TGF-β pathway (Schabort et al., 2009), suggesting that the
individual myomiRs may not regulate these targets in response
to endurance exercise. However, multiple miRNAs may need
to work together to regulate several key proteins involved in
pathway signaling. Following 6 weeks of supervised endurance
training in young sedentary males ∼800 gene transcripts were
regulated and referred to as the training-responsive transcriptome
(TRT) (Timmons et al., 2010). Three DNA sequences identified
as runt-related transcription factor 1 (RUNX1), sex determining
region Y box-9 (SOX9), and paired box gene-3 (PAX3) transcrip-
tion factor binding sites were overexpressed in the TRT post-
training and bioinformatics analyses confirmed RUNX1, SOX9,
and PAX3 as potential modulators of muscle aerobic adaptation.
MiRNA screening of these subjects also identified 14 miRNAs
that were decreased and 7 that were increased in skeletal mus-
cle (Keller et al., 2011). Of the 14 miRNAs that were decreased
miR-92, -98, -101 and 104 were predicted to target RUNX1, SOX9
and PAX3. This suggests that the down regulation of these 4 miR-
NAs during endurance training may permit aerobic adaptation to
occur.
REGULATION OF MicroRNAs IN MYOPATHIES
MiRNAs are essential regulators of skeletal muscle health and
their implication in the onset and progression of myopathies
and chronic diseases associated with muscle wasting and dys-
function is of high interest. Eisenberg and colleagues observed
185 miRNAs to be commonly dysregulated across ten human
primary muscular disorders (Eisenberg et al., 2007). Of these,
miR-146b, miR-155, miR-214, miR-221 and miR-222 were con-
sistently increased in almost all of the disease conditions and
samples tested. Myotonic dystrophy type 1 (DM1) is the most fre-
quently inherited neuromuscular disorder in adults. MiR-206, a
regulator of muscle regeneration (Liu et al., 2012), was specifically
augmented in DM1 patients when compared to healthy controls
(Gambardella et al., 2010). Additionally miR-1 and miR-335 are
upregulated and miR-29b, miR-29c and miR-33 downregulated
in DM1 patients, when compared to control subjects suspected
of a neuromuscular disorder but not presenting any patholog-
ical features (Perbellini et al., 2011). Furthermore, the cellular
localization of miR-1, miR-133b and miR-206 appears disrupted
in DM1 muscle. Similarly, 11 miRNAs, including the muscle
enriched miRNA miR-208, are dysregulated in muscle samples
from patients with myotonic dystrophy type 2 (DM2) (Greco
et al., 2012).
Duchenne muscular dystrophy (DMD) is the most common
and severe form of muscular dystrophy characterized by the
absence of the structural membrane protein dystrophin. The
muscle-enriched miR-206 is downregulated in mdx mice, a well-
established animal model for DMD (McCarthy et al., 2007; Yuasa
et al., 2008) and miR-206 loss-of-function accelerates the dys-
trophic phenotype (Liu et al., 2012). In addition to miR-206,
another 11 miRNAs were found to be dysregulated in both DMD
patients and mdx mice (Greco et al., 2009). In mice, these dys-
regulations could be rescued following therapeutic intervention,
such as HDAC inhibition or restoration of nitric oxide (NO)
signaling; treatments reported to ameliorate the mdx phenotype
(Colussi et al., 2008). In DMD samples, miR-31 andmiR-486 were
also identified as regulators of muscle regeneration (Greco et al.,
2009). In human DMD myoblasts, miR-31 inhibition increases
dystrophin content. MiR-31 modulation is therefore proposed as
a possible therapeutic strategy to ameliorate the DMD phenotype
(Cacchiarelli et al., 2011). Interestingly, miR-486 expression was
not altered in muscle from patients with Becker muscular dys-
trophy who expresses a partially functional dystrophin protein
(Eisenberg et al., 2007).MiR-486 is proposed to play an important
regulatory role in the PTEN (phosphatase and tensin homolog
deleted on chromosome 10)/Akt pathway in dystrophin deficient
(Alexander et al., 2011) and normal muscle (Small et al., 2010).
The sapje mutant zebrafish is a model presenting a more severe
dystrophic phenotype than the mdx mouse (Bassett and Currie,
2004).MiR-199a-5p is elevated in both sapje zebrafish and human
DMD samples when compared to their respective control samples
(Alexander et al., 2013). It was demonstrated that miR-199a-5p
inhibits the expression of several components of the Wnt signal-
ing pathway, a pathway that regulates satellite cell maintenance
and differentiation (Polesskaya et al., 2003; Le Grand et al., 2009).
Chronic diseases associated with muscle wasting are associated
with miRNA dysregulation. MiR-1 downregulation is observed in
patients with chronic obstructive pulmonary disease (COPD) and
is associated with a downregulation of the MRTF-SRF axis (Lewis
et al., 2012); an important transcriptional complex regulating
muscle gene expression (Cen et al., 2004; Charvet et al., 2006;
Miano et al., 2007). Amyotrophic lateral sclerosis (ALS), a severe
motor neuron disorder, is characterized by progressive degener-
ation of upper and lower motor neurons, a decline in strength,
severe muscle atrophy, respiratory insufficiency (Pasinelli and
Brown, 2006) and mitochondrial dysfunction (Menzies et al.,
2002). We have recently identified an increase in miR-23a in
skeletal muscle of ALS patients when compared to healthy con-
trols (Russell et al., 2012). It was established in vitro that
miR-23a negatively regulates peroxisome proliferator-activated
receptor gamma coactivator 1-alpha (PGC-1α) (Russell et al.,
2012), a key activator of mitochondrial biogenesis and function.
Therapeutic inhibition of miR-23a may rescue PGC-1α activity
and ameliorate the ALS phenotype, however this remains to be
established. Sixteen miRNAs were dysregulated in patients with
laminopathies, a class of myopathies presenting mutations in the
lamin A/C gene (Sylvius et al., 2011). Of these, miR-100, miR-192
and miR-135, were directly involved in C2C12 myoblast prolifer-
ation and differentiation. In muscle from children suffering from
dermatomyositis, an upregulation of 33 miRNAs was observed
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(Eisenberg et al., 2007). However, miR-126 was specifically down-
regulated in patients in the early stage of the disease when
compared to healthy controls (Kim et al., 2012). MiR-126 is pro-
posed to play a specific role in the early but not in the late stage
of juvenile dermatomyositis by promoting the expression of the
vascular cell adhesion molecule 1 (VCAM-1), a protein normally
expressed in developing but not in mature healthy muscle fibers.
MiRNAs are responsible for the regulation of numerous gene
networks and pathways in muscle. Consequently, they are impor-
tant modulators of skeletal muscle health and many miRNAs are
dysregulated in specific muscle disease conditions. Some of these
miRNAs play a direct role in muscle cell proliferation or dif-
ferentiation; however, whether the changes observed in miRNA
levels actively contribute or are a consequence of the disease
development remains mostly unknown. Identifying the miRNAs
dysregulated and understanding their role in muscle diseases is
therefore a crucial step in the development of targeted therapeutic
strategies.
AGE-ASSOCIATED REGULATION OF MicroRNAs IN
SKELETAL MUSCLE
Ageing is a condition associated with changes in skeletal muscle
size and function as well as the regulation of miRNAs. Ageing
studies using C. elegans identified changes in miRNAs associated
with lifespan and cellular senescence (Boehm and Slack, 2005;
Ibáñez-Ventoso et al., 2006; Yamakuchi and Lowenstein, 2009;
De Lencastre et al., 2010). Of particular interest, let-7 miRNA is
decreased with age in C. elegans (Ibáñez-Ventoso et al., 2006; De
Lencastre et al., 2010). In contrast, observations in older humans
have identified that twomiRNAs from the let-7 family ofmiRNAs,
let-7b and let-7e, are elevated in skeletal muscle when compared
to young subjects (Drummond et al., 2008a, 2011). The sequence
of C. elegans (cel)-let-7 varies slightly from human (has)-let-7b
and hsa-let-7e and this difference may be sufficient to confer
different mRNA targets for these three miRNAs. Caution must
be taken when comparing the expression of miRNAs between
different species. MiRNAs have historically been named in the
same order as they have been discovered. However, occasional
discrepancies exist between species; therefore, a direct compari-
son between correspondingly named miRNAs cannot always be
made. In addition, the mRNAs targeted by a same miRNA can
differ between species, although their biological function can be
conserved. The function of the let-7 family of miRNAs is similar
in both C. elegans and humans. The primary role of the let-7 miR-
NAs appears to be anti-proliferative, as observed in human cancer
cells (Johnson et al., 2007; Nishino et al., 2008; Dong et al., 2010;
Zhao et al., 2010; Lee et al., 2011) and in mouse neuronal stem
cells (Nishino et al., 2008). The elevation of let-7 miRNAs may
be responsible for the impaired ability to activate and proliferate
satellite cells in the elderly skeletal muscle, therefore contribut-
ing to the attenuated skeletal muscle regenerative capacity in the
elderly (Carlson et al., 2009). Accordingly, bioinformatics analysis
identified cell cycle regulation and cellular growth and prolifer-
ation as the most highly ranked cellular processes likely to be
regulated by the 2 let-7 miRNAs in humans. In old mice with
muscle atrophy, 57 miRNAs were differentially regulated in the
quadriceps when compared to young mice (Hamrick et al., 2010).
Of the dysregulated miRNAs, several were predicted to target
genes involved inmyogenesis, includingMef2, SRF, cardiotrophin
1, myogenin and the cell cycle regulator type IIA activin receptor.
Figure 2 summarizes the known and potential roles of miR-
NAs in myogenesis in the elderly. In order to elucidate which of
these miRNAs are important in the age-related muscle wasting,
their mRNA targets and specific roles in muscle regeneration and
protein synthesis need to be established.
The most natural way to promote muscle growth is by ingest-
ing good quality protein and engaging in resistance exercise
training which is able to stimulate muscle protein synthesis
(Yarasheski et al., 1993; Hasten et al., 2000; Drummond et al.,
2008a; Katsanos et al., 2008; Kumar et al., 2009; Symons et al.,
2009). However, elderly subjects demonstrate an impaired pro-
tein synthetic response to resistance exercise (Cuthbertson et al.,
2005; Kumar et al., 2009). To date, only one study has investigated
the expression of miRNAs in young and old subjects following
a protein-stimulating intervention protocol (Drummond et al.,
2008b). MiR-1, miR-133a and miR-206 were measured in the
muscle of young and old subjects following an acute bout of
resistance exercise and ingestion of essential amino acids (EAA).
Only miR-1 expression was reduced in the young, but not the
old subjects, 3 and 6 h post-exercise and EAA ingestion. A reg-
ulatory role for miR-1 as an IGF-1 inhibitor has previously
been established (McCarthy and Esser, 2007; Elia et al., 2009).
Failure to downregulate miR-1 in elderly subjects following an
FIGURE 2 | The potential role of miRNAs in the attenuated myogenic
process in the elderly. Let-7b and let-7e may contribute to the inhibition of
satellite cell activation and proliferation via downregulating cell cycle
regulators CKD6, CDC25A, and CDC34. In addition miR-181a may inhibit
ActRIIA (activin type IIa receptor) and as a consequence permit activation of
the proliferation inhibitors SMAD2/3. The combination of miR-221 and
miR-698 further inhibits proliferation by down regulating various MRFs and
driving terminal differentiation of the myocytes. Anabolic stimulus is known
to reduce miR-1. Failure to downregulate miR-1 in elderly skeletal muscle
following anabolic stimulation may contribute to anabolic resistance in
mature myotubes via inhibition of IGF-1/Akt signaling., ↑ = stimulatory
pathway; or, T = inhibitory pathway; ↑, upregulated miRNA; ↓,
downregulated miRNA; ?, cause-and-effect relationship not established.
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acute bout of resistance exercise and EAA ingestion may be par-
tially responsible for the attenuated muscle protein synthesis
in response to anabolic stimuli. However, more miRNA targets
need to be investigated to fully appreciate the role of miRNAs
in age-related muscle wasting and to understand the potential
mechanisms attenuating protein synthesis following resistance
exercise.
MicroRNAs AS BIOMARKERS OF DISEASE AND
EXERCISE-INDUCED ADAPTATION
A key feature of miRNAs is their resistance to ribonucleases
(RNases) and therefore their presence and potential stability in
blood (Chen et al., 2008; Gilad et al., 2008; Turchinovich et al.,
2011). Indeed, miRNAs exist within exosomes, lipoprotein and
ribonucleoprotein complexes, which protect them from RNases
digestion (Valadi et al., 2007; Zhang et al., 2010; Vickers et al.,
2011). MiRNAs can be highly expressed in specific tissues, (Sood
et al., 2006) although their role in circulation is not yet clear.
Circulating miRNAs can originate from tissues with hematopoi-
etic cells an abundant source of circulatingmiRNAs (Kosaka et al.,
2010; Pritchard et al., 2012).
The existence and stability of miRNAs in circulation has led
to the search for miRNA biomarkers for various diseases such
as cancer, type 2 diabetes, hepatic diseases and coronary diseases
Table 2 | Regulation of circulating miRNAs by exercise, training, and fitness level.
Author Subjects Model Extraction kit Sample MiRs
Baggish
et al., 2011
Endurance 
athletes
Endurance 
acute exercise 
bout and 
training
MicroRNA 
Extraction Kit, 
Benevbio, 
Mission Viejo, 
CA, USA
Plasma miR-146a miR-21 miR-20a miR-222 miR-221 miR-210 miR-133a miR-328
Uhlemann 
et al., 2012
Not specified
Endurance
acute maximal 
exercise bout
Qiagen 
miRNAeasy, 
Hilden, 
Germany
Plasma miR-126 miR-133
Uhlemann 
et al., 2012
Trained
Endurance
acute 
submaximal 
exercise bout
Qiagen 
miRNAeasy, 
Hilden, 
Germany
Plasma miR-126 miR-133
Uhlemann 
et al., 2012
Trained
Endurance 
marathon race
Qiagen 
miRNAeasy, 
Hilden, 
Germany
Plasma miR-126 miR-133
Uhlemann 
et al., 2012
Trained
Resistance 
acute exercise 
bout
Qiagen 
miRNAeasy, 
Hilden, 
Germany
Plasma miR-126 miR-133
Aoi 
et al., 2013 Untrained
Endurance 
acute exercise 
bout 
TRIzol LS, 
Invitrogen, 
Carlsbad, CA
Serum miR-486
and training miR-486
Bye 
et al., 2013
Low v High 
fitness
miRNeasy Serum miR-210 miR-222 miR-21
Sawada 
et al., 2013
Recreationally 
active
Resistance 
acute exercise 
bout
QIAzol-
chloroform-
column 
extraction
Serum
miR-149* 
(I h post)
miR-146a 
(3 days 
post)
miR-221 (3 
days post)
miR-133a
Roberts 
et al., 2013
Mdx mouse
TRIzol LS, 
Paisley, UK and 
Qiagen 
miRNeasy® 
Mini Kit, 
Crawley, UK
Serum miR-1 miR-133a miR-206 miR-22 miR-30a
miR-
193b
miR-378
Roberts 
et al., 2013
C57B1/10 
mice with 
intramuscular 
cardiotoxin 
injection
TRIzol LS, 
Paisley, UK
Serum miR-1 miR-133a miR-206
Circulating miRNAs regulated by acute exercise were measured immediately post-exercise. Red, downregulated; Green, upregulated; Orange, no change.
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(Chen et al., 2008; Mitchell et al., 2008; D’Alessandra et al., 2010;
Huang et al., 2010; Pigati et al., 2010; Brase et al., 2011; Freedman
et al., 2012). Aberrant expression of specific miRNAs in the cir-
culation may be reflective of disease burden in a specific tissue. It
follows that circulating miRNAs may be beneficial as biomark-
ers for skeletal muscle disease or skeletal muscle adaptation to
exercise. To date, only one study has looked at the circulatingmiR-
NAs dysregulated in a muscle disorder. Roberts et al. identified
an increase in 57 circulating miRNAs in the mdx mouse when
compared to wild-type controls (Roberts et al., 2013), including
miR-1, miR-133a, and miR-206. The same study demonstrated
that miR-1 levels were elevated in the serum of wild-type mice
15min after a cardiotoxin injection in the tibialis anterior mus-
cle, suggesting that high levels of circulating miR-1 are associated
with muscle degeneration and injury.
Changes in plasma and whole blood miRNA profiles have
been observed following acute and chronic exercise and in asso-
ciation with training-induced changes in muscle performance
(Baggish et al., 2011; Uhlemann et al., 2012; Aoi et al., 2013;
Bye et al., 2013; Sawada et al., 2013; Tonevitsky et al., 2013).
Table 2 summarizes the circulating miRNAs regulated by exer-
cise, training and fitness level. Circulating miR-133a increases
immediately following a marathon race and a single bout of resis-
tance exercise (lateral pulldown, leg press, butterfly) (Uhlemann
et al., 2012) but not after a single bout of cycling or tread-
mill exercise (Baggish et al., 2011; Uhlemann et al., 2012) in
trained subjects. In contrast, circulating miR-133a was too lowly
expressed at rest and following cycling exercise to be reliably mea-
sured (Aoi et al., 2013). Immediately following an acute bout
of resistance exercise (bench press and bilateral leg press) in
untrained subjects, no changes in circulating miRNA expression
was observed (Sawada et al., 2013). Circulating miR-21 and miR-
222 are increased following a single bout of cycling exercise and
after 90 days of rowing training (Baggish et al., 2011). However,
circulating miR-21 and miR-222 appear highly expressed in indi-
viduals with low VO2max when compared to individuals with
high VO2max (Bye et al., 2013). These discrepancies may be
explained by differences in the exercise protocols used. However,
it is becoming apparent that various RNA extraction protocols
introduce differences in the expression levels of the measured
miRNAs (McAlexander et al., 2013). In addition, hemolysis is
a major source of plasma miRNAs (Pritchard et al., 2012) and
caution needs to be taken during blood draw and plasma sepa-
ration to avoid miRNA contamination from red blood cells. The
expression of plasma miRNAs derived from hematopoietic cells
correlates strongly with hematopoietic cell number (Pritchard
et al., 2012). Therefore, changes in circulating miRNA levels
within subjects may reflect exercise-induced changes in blood cell
numbers (Tanimura et al., 2009; Connes et al., 2013; Tonevitsky
et al., 2013) rather than muscle-specific adaptations. Tonevitsky
et al. completed a miRNA array in whole blood of trained
individuals following a single bout of treadmill exercise. MiR-21-
5p, miR-24-2-5p, miR-27a-5p, miR-181a-5p and miR-181b-5p
were all regulated immediately post-exercise and during recov-
ery (Tonevitsky et al., 2013). Bioinformatics analysis predicted
these miRNAs to target exercise-responsive processes including
immune function, apoptosis, membrane trafficking and tran-
scriptional regulation. However, these relationships have not been
experimentally validated.
An ideal miRNA biomarker candidate for muscle disease or
adaptation to exercise should not be expressed by hematopoi-
etic cells but rather be predominantly expressed in the tissue of
interest, such as miR-133a (Callis et al., 2008) and miR-210; the
latter described as a hypoximiR (Devlin et al., 2011). More work
is required to determine whether circulating miRNAs can serve
as stable blood-based biomarkers for underlying skeletal muscle
diseases and exercise-induced muscle adaptations.
CONCLUDING REMARKS
MiRNAs are positive regulators of myogenesis. Their expression
levels change following a single bout of exercise and exercise train-
ing and following nutritional interventions. A dysregulation of
various miRNAs occurs in myopathies, in chronic diseases asso-
ciated with muscle atrophy as well as with ageing. These obser-
vations suggest that skeletal muscle miRNAs play an important
role in muscle adaptation and maladaptation. The identification
of circulating miRNAs and their regulation following exercise and
in disease suggests that they may be useful biomarkers of health
and adaptation to treatment interventions. These observations
also imply that miRNAs might be amenable to therapeutic inter-
vention. However, at present we have little knowledge relating to
how changes in skeletal muscle or circulating miRNAs influence,
either directly or indirectly, changes in skeletal muscle regener-
ation, size, function, metabolism and consequently whole body
health. Establishing the causal roles of skeletal muscle miRNAs
in vivo is now required to significantly advance this exciting field.
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